These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
187 related items for PubMed ID: 14977084
1. Molecular analysis of p21 promoter activity isolated from squamous carcinoma cell lines of the head and neck under the influence of 1,25(OH)2 vitamin D3 and its analogs. Hager G, Kornfehl J, Knerer B, Weigel G, Formanek M. Acta Otolaryngol; 2004 Jan; 124(1):90-6. PubMed ID: 14977084 [Abstract] [Full Text] [Related]
2. 1,25(OH)2 vitamin D3 induces elevated expression of the cell cycle-regulating genes P21 and P27 in squamous carcinoma cell lines of the head and neck. Hager G, Formanek M, Gedlicka C, Thurnher D, Knerer B, Kornfehl J. Acta Otolaryngol; 2001 Jan; 121(1):103-9. PubMed ID: 11270487 [Abstract] [Full Text] [Related]
3. Regulation of gene Expression by 1alpha,25-dihydroxyvitamin D3 and Its analog EB1089 under growth-inhibitory conditions in squamous carcinoma Cells. Akutsu N, Lin R, Bastien Y, Bestawros A, Enepekides DJ, Black MJ, White JH. Mol Endocrinol; 2001 Jul; 15(7):1127-39. PubMed ID: 11435613 [Abstract] [Full Text] [Related]
4. 1,25(OH)2Vitamin D3 induces elevated expression of the cell cycle inhibitor p18 in a squamous cell carcinoma cell line of the head and neck. Gedlicka C, Hager G, Weissenböck M, Gedlicka W, Knerer B, Kornfehl J, Formanek M. J Oral Pathol Med; 2006 Sep; 35(8):472-8. PubMed ID: 16918598 [Abstract] [Full Text] [Related]
5. 1,25-Dihydroxycholecalciferol (1,25-D3) inhibits the growth of squamous cell carcinoma and down-modulates p21(Waf1/Cip1) in vitro and in vivo. Hershberger PA, Modzelewski RA, Shurin ZR, Rueger RM, Trump DL, Johnson CS. Cancer Res; 1999 Jun 01; 59(11):2644-9. PubMed ID: 10363987 [Abstract] [Full Text] [Related]
6. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines. Koike M, Koshizuka K, Kawabata H, Yang R, Taub HE, Said J, Uskokovic M, Tsuruoka N, Koeffler HP. Anticancer Res; 1999 Jun 01; 19(3A):1689-97. PubMed ID: 10470102 [Abstract] [Full Text] [Related]
7. Action of low calcemic 1alpha,25-dihydroxyvitamin D3 analogue EB1089 in head and neck squamous cell carcinoma. Prudencio J, Akutsu N, Benlimame N, Wang T, Bastien Y, Lin R, Black MJ, Alaoui-Jamali MA, White JH. J Natl Cancer Inst; 2001 May 16; 93(10):745-53. PubMed ID: 11353784 [Abstract] [Full Text] [Related]
8. Inhibition of MG-63 cell cycle progression by synthetic vitamin D3 analogs mediated by p27, Cdk2, cyclin E, and the retinoblastoma protein. Ryhänen S, Jääskeläinen T, Mahonen A, Mäenpää PH. Biochem Pharmacol; 2003 Aug 01; 66(3):495-504. PubMed ID: 12907249 [Abstract] [Full Text] [Related]
9. Inhibition of F-Box protein p45(SKP2) expression and stabilization of cyclin-dependent kinase inhibitor p27(KIP1) in vitamin D analog-treated cancer cells. Lin R, Wang TT, Miller WH, White JH. Endocrinology; 2003 Mar 01; 144(3):749-53. PubMed ID: 12586749 [Abstract] [Full Text] [Related]
10. Vitamin D analogs: new therapeutic agents for the treatment of squamous cancer and its associated hypercalcemia. Yu J, Papavasiliou V, Rhim J, Goltzman D, Kremer R. Anticancer Drugs; 1995 Feb 01; 6(1):101-8. PubMed ID: 7756673 [Abstract] [Full Text] [Related]
11. Vitamin D3 analogs and their 24-oxo metabolites equally inhibit clonal proliferation of a variety of cancer cells but have differing molecular effects. Campbell MJ, Reddy GS, Koeffler HP. J Cell Biochem; 1997 Sep 01; 66(3):413-25. PubMed ID: 9257197 [Abstract] [Full Text] [Related]
12. MART-10, a novel vitamin D analog, inhibits head and neck squamous carcinoma cells growth through cell cycle arrest at G0/G1 with upregulation of p21 and p27 and downregulation of telomerase. Chiang KC, Yeh CN, Hsu JT, Chen LW, Kuo SF, Sun CC, Huang CC, Pang JH, Flanagan JN, Takano M, Kittaka A, Juang HH, Yang SW, Chen TC. J Steroid Biochem Mol Biol; 2013 Nov 01; 138():427-34. PubMed ID: 24044969 [Abstract] [Full Text] [Related]
13. Expression profiling in squamous carcinoma cells reveals pleiotropic effects of vitamin D3 analog EB1089 signaling on cell proliferation, differentiation, and immune system regulation. Lin R, Nagai Y, Sladek R, Bastien Y, Ho J, Petrecca K, Sotiropoulou G, Diamandis EP, Hudson TJ, White JH. Mol Endocrinol; 2002 Jun 01; 16(6):1243-56. PubMed ID: 12040012 [Abstract] [Full Text] [Related]
14. Antiproliferative effects of the biologically active metabolite of vitamin D3 (1,25 [OH]2 D3) on head and neck squamous cell carcinoma cell lines. Kornfehl J, Formanek M, Temmel A, Knerer B, Willheim M. Eur Arch Otorhinolaryngol; 1996 Jun 01; 253(6):341-4. PubMed ID: 8858258 [Abstract] [Full Text] [Related]
15. Sensitive induction of apoptosis in breast cancer cells by a novel 1,25-dihydroxyvitamin D3 analogue shows relation to promoter selectivity. Danielsson C, Mathiasen IS, James SY, Nayeri S, Bretting C, Hansen CM, Colston KW, Carlberg C. J Cell Biochem; 1997 Sep 15; 66(4):552-62. PubMed ID: 9282333 [Abstract] [Full Text] [Related]
16. Novel 19-nor-hexafluoride vitamin D3 analog (Ro 25-6760) inhibits human colon cancer in vitro via apoptosis. Evans SR, Soldatenkov V, Shchepotin EB, Bogrash E, Shchepotin IB. Int J Oncol; 1999 May 15; 14(5):979-85. PubMed ID: 10200351 [Abstract] [Full Text] [Related]
17. Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy. Díaz GD, Paraskeva C, Thomas MG, Binderup L, Hague A. Cancer Res; 2000 Apr 15; 60(8):2304-12. PubMed ID: 10786699 [Abstract] [Full Text] [Related]
19. The effects of 1alpha,25-dihydroxyvitamin D3 on the expression of DNA replication genes. Eelen G, Verlinden L, van Camp M, van Hummelen P, Marchal K, de Moor B, Mathieu C, Carmeliet G, Bouillon R, Verstuyf A. J Bone Miner Res; 2004 Jan 15; 19(1):133-46. PubMed ID: 14753745 [Abstract] [Full Text] [Related]
20. Autocrine TGFbeta signaling mediates vitamin D3 analog-induced growth inhibition in breast cells. Yang L, Yang J, Venkateswarlu S, Ko T, Brattain MG. J Cell Physiol; 2001 Sep 15; 188(3):383-93. PubMed ID: 11473365 [Abstract] [Full Text] [Related] Page: [Next] [New Search]